Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration

Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration

<b>Background/Objectives</b>: Exudative age-related macular degeneration (AMD) is a disease of choroidal neovascularization that causes blindness. Current treatments to preserve vision in this prevalent and blinding condition are repeat intraocular injections of anti-vascular endothelial...

Full description

Saved in:
Bibliographic Details
Main Authors: Valory Anne S. Vailoces, Andrew J. Tolentino, Jose Fernando Arevalo, Ron A. Adelman, Robert Bhisitkul, Diana V. Do, Quan Dong Nguyen, Michael J. Tolentino, Masaki Tanito, Hiroaki Serizawa
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Pharmaceuticals
Subjects:
macular degeneration
rifampicin
rifamycin
anti-angiogenesis
VEGF
eye drops
Online Access:https://www.mdpi.com/1424-8247/18/5/655
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/5/655

Similar Items